Therapeutic Proteins: Routes of Exposure and the risk of immunogenicity

Immunogenicity risk management includes risk assessment and risk mitigation strategies. Knowledge about immune mechanisms is critical for improving the accuracy of risk assessments as uncertainty in knowledge about a risk factor increases its risk categorization. This talk will explore the impact of sub cutaneous, intra venous, and oral routes of exposure on the immunogenicity of therapeutic proteins.